2021 Oct;28(4):272-281.

Clinical and immunological assessment of children with ataxia telangiectasia attending Sohag university hospital in Upper Egypt



  • 1Department of Pediatric, Sohag General Hospital, Sohag, Egypt.
  • 2Department of Clinical Pathology, Sohag General Hospital, Sohag, Egypt.
  • 3Department of Medical Microbiology & Immunology , Faculty of Medicine, Assiut University, Assiut, Egypt.
  • PMID: 34882376


Ataxia Telangiectasia (AT) is a very rare autosomal recessive primary immune deficiency (PID) disease that affects 1 in 10,000-40,000 new births per year in the world. It is caused by biallelic mutations in ataxia telangiectasia mutated (ATM) gene and characterized by a progressive cerebellar ataxia. The clinical profile of AT children in Upper Egypt in missing. Herein, we evaluated the clinical characteristics and immunological profiles of patients with AT attending Sohag University Hospital. This was a cross-sectional study, included 21 AT patients attending the Neurological and Immunological Units, Pediatric Department, Sohag University Hospital, starting April 2018 to the end of March 2019. AT represented 20.5% of all PID patients attending the hospital. The most common type of humoral immune deficiency in patients with AT was specific IgA deficiency (52.3%) followed by hypogammaglobulinemia (23.8%). Recurrent sinopulmonary infection with different degrees of severity was the common immunological problem. The most common neurological manifestations in our studied patients, other than the ataxia, were language delay and eye movement abnormalities followed by developmental delay and head nodding. None of our patients had developed malignancy till the end of the study.